1-6 of 6
Ronald Herbst
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Discovery and Development of MEDI7247, a Novel Pyrrolobenzodiazepine (PBD)-Based Antibody Drug Conjugate Targeting ASCT2, for Treating Hematological Cancers

Nabendu Pore, Kevin P Schifferli, Noel R Monks, Ravinder Tammali, Martin Borrok, Elaine Hurt, Matt Flynn, Marlon Rebelatto, Danielle M. Townsley, MD MSc, Mary Jane Hinrichs, Rakesh Dixit, Steven Coats, Ronald Herbst, David Tice
Journal: Blood
Blood (2018) 132 (Supplement 1): 4071.
https://doi.org/10.1182/blood-2018-99-119836
Published: 2018
Journal Articles

Preclinical Evaluation of MEDI2228, a BCMA-Targeting Pyrrolobenzodiazepine-Linked Antibody Drug Conjugate for the Treatment of Multiple Myeloma

Krista Kinneer, John Meekin, Reena Varkey, Xiaodong Xiao, Haihong Zhong, Shannon Breen, Elaine Hurt, Suneetha Thomas, Matt Flynn, Paul Hynes, Binyam Bezabeh, Cui (Tracy) Chen, Leslie Wetzel, Ruoyan Chen, Yu-Tzu Tai, PhD, Kenneth C Anderson, MD, Ronald Herbst, David Tice
Journal: Blood
Blood (2017) 130 (Supplement 1): 3153.
https://doi.org/10.1182/blood.V130.Suppl_1.3153.3153
Published: 2017
Journal Articles

A microRNA Signature Predicts Response to Anti-CD19 Therapy (MEDI-551) in B-Cell Malignancies

Katie Streicher, PhD, Philip Brohawn, Mike Kuziora, Fernanda Pilataxi, Brandon Higgs, Kim Lehmann, Kathleen McKeever, Trishna Goswami, MD, Ronald Herbst, PhD, Yihong Yao, Koustubh Ranade
Journal: Blood
Blood (2014) 124 (21): 2198.
https://doi.org/10.1182/blood.V124.21.2198.2198
Published: 2014
Journal Articles

Safety Profile and Clinical Response To MEDI-551, a Humanized Monoclonal Anti-CD19, In a Phase 1/2 Study In Adults With Relapsed Or Refractory Advanced B-Cell Malignancies

Andres Forero-Torres, MD, Mehdi Hamadani, MD, Michelle A. Fanale, MD, Celeste M. Bello, MD, Thomas J. Kipps, MD, PhD, Fritz Offner, MD, Gregor Verhoef, Massimo Federico, MD, Stephanie A. Gregory, MD, Anne Sonet, MD, Sarit Assouline, MD, Jaime Pérez de Oteyza, Jose Francisco Tomas, MD, Antonio Cuneo, MD, Nairouz Elgeioushi, MPH, Trishna Goswami, MD, Ramy Ibrahim, MD, Ronald Herbst, PhD, Bruce D. Cheson, M.D.
Journal: Blood
Blood (2013) 122 (21): 1810.
https://doi.org/10.1182/blood.V122.21.1810.1810
Published: 2013
Journal Articles

MEDI-551, a Humanized Monoclonal Anti-CD19, in Adults with Relapsed or Refractory Advanced B-Cell Malignancies: Results From a Phase 1/2 Study

Andres Forero, MD, Mehdi Hamadani, MD, Michelle A. Fanale, MD, Celeste M. Bello, MD, Thomas J Kipps, MD, PhD, Fritz Offner, Gregor Verhoef, Massimo Federico, MD, Stephanie A. Gregory, MD, Anne Sonet, MD, Sarit Assouline, Jaime Pérez de Oteyza, Jose Francisco Tomas, Antonio Cuneo, MD, Weiya Zhang, Trishna Goswami, MD, Ramy Ibrahim, MD, Zhenling Yao, Ronald Herbst, PhD, Bruce D. Cheson, MD
Journal: Blood
Blood (2012) 120 (21): 3677.
https://doi.org/10.1182/blood.V120.21.3677.3677
Published: 2012
Journal Articles

Live Cell Imaging Captures Immune Cell-Mediated Killing of Precursor-B Acute Lymphoblastic Leukemia Cells Targeted with Anti-CD19 (Medi-551) Antibodies: Support for Macrophage and NK Cell In Vivo Activity

Ksenia Matlawska-Wasowska, PhD, Dennis Cook, Samuel R. Stevens, Elizabeth K. Ward, Ronald Herbst, PhD, Stuart S. Winter, MD, Bridget S. Wilson, PhD
Journal: Blood
Blood (2011) 118 (21): 1522.
https://doi.org/10.1182/blood.V118.21.1522.1522
Published: 2011